greeksoup/ stock research

Privia Health Group (PRVA) FY2024 results: revenue $1.7 billion, up 4.7% on the year

Privia Health Group, Inc. (PRVA) reported revenue of $1.7 billion for fiscal 2024, the year ended 31 December 2024, up 4.7% on the year before. Net income was $14 million, down 37.7%, and diluted earnings per share $0.11. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2025.

Revenue
$1.7 billion
+4.7% on the year
FY2019FY2024
Operating margin
1.0%
1.2% a year earlier
FY2019FY2024
Net income
$14 million
-37.7% on the year
FY2019FY2024
Diluted EPS
$0.11
-42.1% on the year
FY2019FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue1,7361,6581,357+4.7%
Operating income17.020.6-19.1-17.8%
Operating margin1.0%1.2%-1.4%
Interest expensen/an/a0.5
Pre-tax income27.929.0-18.6-4.0%
Income tax10.88.0-6.5+35.4%
Effective tax rate38.8%27.5%n/a
Net income14.423.1-8.6-37.7%
Net margin0.8%1.4%-0.6%
Diluted EPS$0.11$0.19-$0.08-42.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow10980.847.2+35.3%
Capital expendituren/a0.10.1
Free cash flown/a80.747.1
Free cash flow marginn/a4.9%3.5%
Cash from investing-12.0-43.0-0.1
Cash from financing4.33.7-19.7+17.0%
Depreciation and amortisation7.36.54.6+11.3%
Share-based compensation56.737.167.4+52.8%
Diluted shares, weighted126m125m111m+0.7%
Shares outstanding at period end120m118m115m+1.8%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity635561499+13.1%
Non-controlling interest48.346.020.0+5.0%
Debt0.00.00.0
Operating lease liabilities3.05.28.5-42.1%
Other liabilities449387265+16.0%
Total liabilities and equity1,1361,000793+13.6%
Fixed assets1.22.33.4-46.6%
Goodwill142139127+2.1%
Intangible assets11010857.4+2.0%
Cash and equivalents491390348+26.1%
Receivables316291190+8.7%
Other assets75.870.967.5+6.9%
Total assets1,1361,000793+13.6%

10-K for the year ended 31 December 2024, filed 27 February 2025: the filing.